sellModerate cluster of 610b5-1 plan
Sheena Jonathan sold $5.6M of NTRA
director, other at Natera, Inc.. 36,300 shares at an average of $154.86, traded Nov 13, 2024, filed Nov 15, 2024.
Warning score
40Value
$5.6M
36,300 shares
Holdings after
47,782
-13% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001415889-24-027014, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 13, 2024 | SOpen-market sale Common Stock10b5-1 | -8,026 | $152.69 | $1.2M | 271,746 | Nov 15, 2024 |
| Nov 13, 2024 | SOpen-market sale Common Stock10b5-1 | -11,974 | $154.11 | $1.8M | 259,772 | Nov 15, 2024 |
| Nov 13, 2024 | SOpen-market sale Common Stockindirect: By Caraluna 1 Trust10b5-1 | -4,011 | $152.78 | $613k | 51,921 | Nov 15, 2024 |
| Nov 13, 2024 | SOpen-market sale Common Stockindirect: By Caraluna 1 Trust10b5-1 | -64 | $153.51 | $9,825 | 51,857 | Nov 15, 2024 |
| Nov 13, 2024 | SOpen-market sale Common Stockindirect: By Caraluna 1 Trust10b5-1 | -4,075 | $160.02 | $652k | 47,782 | Nov 15, 2024 |
| Nov 13, 2024 | SOpen-market sale Common Stockindirect: By Caraluna 2 Trust10b5-1 | -3,617 | $152.93 | $553k | 52,315 | Nov 15, 2024 |
| Nov 13, 2024 | SOpen-market sale Common Stockindirect: By Caraluna 2 Trust10b5-1 | -458 | $154.40 | $71k | 51,857 | Nov 15, 2024 |
| Nov 13, 2024 | SOpen-market sale Common Stockindirect: By Caraluna 2 Trust10b5-1 | -4,075 | $160.02 | $652k | 47,782 | Nov 15, 2024 |
Related signals
Other insiders at Natera, Inc. and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 25Weak | sell 510b5-1 | NTRA Natera, Inc. | Fesko John PRESIDENT, CHIEF BUS. OFFICER | $107k | 669 | |
| 31Weak | sell 510b5-1 | NTRA Natera, Inc. | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | $388k | 2,428 | |
| 34Weak | sell 510b5-1 | NTRA Natera, Inc. | Sheena Jonathan director, other | $953k | 5,700 | |
| 40Moderate | sell 610b5-1 | NTRA Natera, Inc. | Rabinowitz Matthew EXECUTIVE CHAIRMAN | $27M | 160,000 | |
| 49Moderate | sell 6 | NTRA Natera, Inc. | Chapman Rowan E director | $301k | 1,767 | |
| 22Weak | sell 610b5-1 | NTRA Natera, Inc. | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | $809k | 4,858 | |
| 55Moderate | sell 5 | NTRA Natera, Inc. | BOTHA ROELOF director | $15M | 87,473 | |
| 35Weak | sell 710b5-1 | NTRA Natera, Inc. | Rabinowitz Matthew EXECUTIVE CHAIRMAN | $665k | 4,000 | |
| 65Notable | sell 6 | NTRA Natera, Inc. | Marcus Gail Boxer director | $1.5M | 9,682 | |
| 40Moderate | sell 510b5-1 | NTRA Natera, Inc. | Baynes Roy D. director | $5.4M | 37,230 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.